| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.008 |